找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Screening and Risk Reduction Strategies for Breast Cancer; Imaging Modality and Masakazu Toi Book 2023 The Editor(s) (if applicable) and Th

[復(fù)制鏈接]
查看: 45761|回復(fù): 52
樓主
發(fā)表于 2025-3-21 16:05:52 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Screening and Risk Reduction Strategies for Breast Cancer
副標(biāo)題Imaging Modality and
編輯Masakazu Toi
視頻videohttp://file.papertrans.cn/863/862889/862889.mp4
概述Touch upon current topics in breast cancer screening.More individualized screening system for breast cancers are focused upon.Possible understand background and advances on the risk reduction of breas
圖書封面Titlebook: Screening and Risk Reduction Strategies for Breast Cancer; Imaging Modality and Masakazu Toi Book 2023 The Editor(s) (if applicable) and Th
描述.This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening...A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book. ?An in-depth review of these modalities
出版日期Book 2023
關(guān)鍵詞individualized screening; tumor heterogenity; risk reduction; lifetime risk; disease characteristics
版次1
doihttps://doi.org/10.1007/978-981-19-7630-8
isbn_softcover978-981-19-7632-2
isbn_ebook978-981-19-7630-8
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

書目名稱Screening and Risk Reduction Strategies for Breast Cancer影響因子(影響力)




書目名稱Screening and Risk Reduction Strategies for Breast Cancer影響因子(影響力)學(xué)科排名




書目名稱Screening and Risk Reduction Strategies for Breast Cancer網(wǎng)絡(luò)公開度




書目名稱Screening and Risk Reduction Strategies for Breast Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Screening and Risk Reduction Strategies for Breast Cancer被引頻次




書目名稱Screening and Risk Reduction Strategies for Breast Cancer被引頻次學(xué)科排名




書目名稱Screening and Risk Reduction Strategies for Breast Cancer年度引用




書目名稱Screening and Risk Reduction Strategies for Breast Cancer年度引用學(xué)科排名




書目名稱Screening and Risk Reduction Strategies for Breast Cancer讀者反饋




書目名稱Screening and Risk Reduction Strategies for Breast Cancer讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:26:12 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:52:06 | 只看該作者
地板
發(fā)表于 2025-3-22 04:43:13 | 只看該作者
Hereditary Breast Cancer and Pathogenic Germline Variants,nd treatment of HBC. A hallmark of breast cancers is their heterogeneous nature, and it is paramount to understand the biological and clinical significance of pathogenic germline variants (PGVs) in terms of risk level and the features of PGV-associated tumours. Genetic screening can potentially be e
5#
發(fā)表于 2025-3-22 08:43:39 | 只看該作者
6#
發(fā)表于 2025-3-22 14:42:38 | 只看該作者
7#
發(fā)表于 2025-3-22 18:09:20 | 只看該作者
Risk-Reducing Surgery for Breast Cancer,ting continues to rise. Nonetheless, despite these advances in genetics, approximately 30% of familial breast cancer risk remains unaccounted for by mutations in currently known genes. Moreover, genetic changes do not necessarily have a causative association with a diseased state, and phenotypic man
8#
發(fā)表于 2025-3-22 23:18:13 | 只看該作者
9#
發(fā)表于 2025-3-23 04:03:47 | 只看該作者
Biomarkers in Proteomics, proteomics sector in future. With the help of proteomics, humanity can expand its biological knowledge far beyond. For example, the proteome information can hugely impact the cancer studies in the medical and bio-healthcare sector. There has been increased number of journals publishing importance o
10#
發(fā)表于 2025-3-23 05:51:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 21:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
甘肃省| 慈溪市| 右玉县| 双峰县| 乌拉特后旗| 三亚市| 泰宁县| 肃宁县| 西充县| 平原县| 松溪县| 汉源县| 新化县| 泰来县| 德格县| 上栗县| 朝阳县| 石河子市| 陕西省| 忻州市| 靖江市| 克什克腾旗| 绥滨县| 衡山县| 若尔盖县| 海兴县| 郧西县| 泸州市| 施秉县| 板桥市| 新民市| 乌兰察布市| 巴彦县| 永平县| 大冶市| 建湖县| 江西省| 上思县| 瓮安县| 江川县| 淳化县|